348 related articles for article (PubMed ID: 28091728)
1. Value of Nonrigid Registration of Pre-Procedure MR with Post-Procedure CT After Radiofrequency Ablation for Hepatocellular Carcinoma.
Park J; Lee JM; Lee DH; Joo I; Yoon JH; Park JY; Klotz E
Cardiovasc Intervent Radiol; 2017 Jun; 40(6):873-883. PubMed ID: 28091728
[TBL] [Abstract][Full Text] [Related]
2. Prediction of Local Tumor Progression after Radiofrequency Ablation (RFA) of Hepatocellular Carcinoma by Assessment of Ablative Margin Using Pre-RFA MRI and Post-RFA CT Registration.
Yoon JH; Lee JM; Klotz E; Woo H; Yu MH; Joo I; Lee ES; Han JK
Korean J Radiol; 2018; 19(6):1053-1065. PubMed ID: 30386137
[TBL] [Abstract][Full Text] [Related]
3. Safety margin assessment after radiofrequency ablation of the liver using registration of preprocedure and postprocedure CT images.
Kim KW; Lee JM; Klotz E; Kim SJ; Kim SH; Kim JY; Han JK; Choi BI
AJR Am J Roentgenol; 2011 May; 196(5):W565-72. PubMed ID: 21512046
[TBL] [Abstract][Full Text] [Related]
4. Imaging evaluation of ablative margin and index tumor immediately after radiofrequency ablation for hepatocellular carcinoma: comparison between multidetector-row CT and MR imaging.
Kim SM; Shin SS; Lee BC; Kim JW; Heo SH; Lim HS; Jeong YY
Abdom Radiol (NY); 2017 Oct; 42(10):2527-2537. PubMed ID: 28409202
[TBL] [Abstract][Full Text] [Related]
5. Postablation assessment using follow-up registration of CT images before and after radiofrequency ablation (RFA): prospective evaluation of midterm therapeutic results of RFA for hepatocellular carcinoma.
Shin S; Lee JM; Kim KW; Joo I; Han JK; Choi BI; Klotz E
AJR Am J Roentgenol; 2014 Jul; 203(1):70-7. PubMed ID: 24951197
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of hepatocellular carcinoma ablative margins using fused pre- and post-ablation hepatobiliary phase images.
Takeyama N; Mizobuchi N; Sakaki M; Shimozuma Y; Munechika J; Kajiwara A; Uchikoshi M; Uozumi S; Ohgiya Y; Gokan T
Abdom Radiol (NY); 2019 Mar; 44(3):923-935. PubMed ID: 30327828
[TBL] [Abstract][Full Text] [Related]
7. 3D fusion is superior to 2D point-to-point contrast-enhanced US to evaluate the ablative margin after RFA for hepatocellular carcinoma.
Long H; Zhou X; Zhang X; Ye J; Huang T; Cong L; Xie X; Huang G
Eur Radiol; 2024 Feb; 34(2):1247-1257. PubMed ID: 37572191
[TBL] [Abstract][Full Text] [Related]
8. Safety margin of radiofrequency ablation for hepatocellular carcinoma: a prospective study using magnetic resonance imaging with superparamagnetic iron oxide.
Fukuda K; Mori K; Hasegawa N; Nasu K; Ishige K; Okamoto Y; Shiigai M; Abei M; Minami M; Hyodo I
Jpn J Radiol; 2019 Jul; 37(7):555-563. PubMed ID: 31102138
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of three-dimensional Gd-EOB-DTPA-enhanced MR fusion imaging with CT fusion imaging in the assessment of treatment effect of radiofrequency ablation of hepatocellular carcinoma.
Makino Y; Imai Y; Igura T; Hori M; Fukuda K; Sawai Y; Kogita S; Fujita N; Takehara T; Murakami T
Abdom Imaging; 2015 Jan; 40(1):102-11. PubMed ID: 25052767
[TBL] [Abstract][Full Text] [Related]
10. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
[TBL] [Abstract][Full Text] [Related]
11. Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation.
Laimer G; Schullian P; Jaschke N; Putzer D; Eberle G; Alzaga A; Odisio B; Bale R
Eur Radiol; 2020 May; 30(5):2463-2472. PubMed ID: 32002642
[TBL] [Abstract][Full Text] [Related]
12. Combined transarterial chemoembolization and radiofrequency ablation for small treatment-naïve hepatocellular carcinoma infeasible for ultrasound-guided radiofrequency ablation: long-term outcomes.
Hyun D; Cho SK; Shin SW; Park KB; Lee SY; Park HS; Do YS
Acta Radiol; 2018 Jul; 59(7):773-781. PubMed ID: 29034691
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma.
Kang TW; Rhim H; Lee J; Song KD; Lee MW; Kim YS; Lim HK; Jang KM; Kim SH; Gwak GY; Jung SH
Eur Radiol; 2016 Oct; 26(10):3437-46. PubMed ID: 26747262
[TBL] [Abstract][Full Text] [Related]
14. Fusion of Preinterventional MR Imaging With Liver Perfusion CT After RFA of Hepatocellular Carcinoma: Early Quantitative Prediction of Local Recurrence.
Kobe A; Kindler Y; Klotz E; Puippe G; Messmer F; Alkadhi H; Pfammatter T
Invest Radiol; 2021 Mar; 56(3):188-196. PubMed ID: 32932379
[TBL] [Abstract][Full Text] [Related]
15. Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers.
Bo XW; Xu HX; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K; Wang D
Br J Radiol; 2017 Oct; 90(1078):20170063. PubMed ID: 28749166
[TBL] [Abstract][Full Text] [Related]
16. Initial radiofrequency ablation failure for hepatocellular carcinoma: repeated radiofrequency ablation versus transarterial chemoembolisation.
Kim SS; Kang TW; Kim M; Lee MW; Cho SK; Paik YH; Kim MJ
Clin Radiol; 2018 Feb; 73(2):216.e1-216.e8. PubMed ID: 28859852
[TBL] [Abstract][Full Text] [Related]
17. Coronal reformatted CT images contribute to the precise evaluation of the radiofrequency ablative margin for hepatocellular carcinoma.
Motoyama T; Ogasawara S; Chiba T; Higashide T; Yokota H; Kanogawa N; Suzuki E; Ooka Y; Tawada A; Irie R; Ochi S; Masuda Y; Uno T; Yokosuka O
Abdom Imaging; 2014 Apr; 39(2):262-8. PubMed ID: 24346490
[TBL] [Abstract][Full Text] [Related]
18. 3-D Contrast-Enhanced Ultrasound Fusion Imaging: A New Technique to Evaluate the Ablative Margin of Radiofrequency Ablation for Hepatocellular Carcinoma.
Zhang X; Huang G; Ye J; Xu M; Cong L; He X; Huang T; Kuang M; Xie X
Ultrasound Med Biol; 2019 Aug; 45(8):1933-1943. PubMed ID: 31109841
[TBL] [Abstract][Full Text] [Related]
19. Three-Dimensional Measurement of Hepatocellular Carcinoma Ablation Zones and Margins for Predicting Local Tumor Progression.
Hocquelet A; Trillaud H; Frulio N; Papadopoulos P; Balageas P; Salut C; Meyer M; Blanc JF; Montaudon M; Denis de Senneville B
J Vasc Interv Radiol; 2016 Jul; 27(7):1038-1045.e2. PubMed ID: 27156743
[TBL] [Abstract][Full Text] [Related]
20. A feasibility study: evaluation of radiofrequency ablation therapy to hepatocellular carcinoma using image registration of preoperative and postoperative CT.
Fujioka C; Horiguchi J; Ishifuro M; Kakizawa H; Kiguchi M; Matsuura N; Hieda M; Tachikake T; Alam F; Furukawa T; Ito K
Acad Radiol; 2006 Aug; 13(8):986-94. PubMed ID: 16843851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
